Michael Douglas Taylor, President and CEO at Deciphera Pharmaceuticals, Inc. (DCPH), sold 14,365 shares at $28.01 ($410K) on 2019-02-15, disclosed to the SEC on 2019-02-19.
Open-market sale of $410k DCPH by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.00 | 500 | $14K | 3.4% |
| 2 | $28.01 | 4,934 | $138K | 33.7% |
| 3 | $28.01 | 4,934 | $138K | 33.7% |
| 4 | $30.00 | 3,997 | $120K | 29.2% |
| Total | $28.56 avg | 14,365 | $410K | 100% |
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |